Background illustration for clinical trials search

Paid Clinical Trials Atlanta

Discover 1,670 paid clinical trials in Atlanta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics

for
HIV Infections
Location: Atlanta GA, Tampa FL, Washington DC, Miami FL,
Sponsor: ViiV Healthcare

Sex: All

Age: 6 - 12

Code: NCT05674656

Phase 1, Phase 2, Recruiting

DFT383 in Pediatric Participants With Nephropathic Cystinosis

for
Nephropathic Cystinosis
Location: Atlanta GA, Philadelphia PA, Houston TX, Phoenix AZ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 5

Code: NCT06910813

Phase 1, Phase 2, Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Atlanta GA, Augusta GA, Birmingham AL, Montgomery AL,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase 2, Recruiting
New

HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor

for
Solid Tumors, Adult
Location: Atlanta GA, Tamarac FL, Plantation FL
Sponsor: Hutchmed

Sex: All

Age: 18+

Code: NCT07396584

Phase 1, Phase 2, Recruiting

Letrozole in Uterine Leiomyosarcoma

for
Uterine Leiomyosarcoma
Location: Atlanta GA, Greenville NC, New Orleans LA,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT05649956

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Atlanta GA, Birmingham AL, Nashville TN,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06369285

Phase 2, Recruiting

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

for
Indolent Systemic Mastocytosis,
Location: Atlanta GA, Birmingham AL, Durham NC, Cincinnati OH,
Sponsor: Blueprint Medicines Corporation

Sex: All

Age: 18+

Code: NCT04910685

Phase 2, Phase 3, Recruiting

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

for
Advanced Systemic Mastocytosis (AdvSM),
Location: Atlanta GA, Charleston SC, Houston TX, Toronto,
Sponsor: Cogent Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04996875

Phase 2, Recruiting

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

for
Multiple Myeloma, Myeloma, Myeloma Multiple
Location: Atlanta GA, Nashville TN, Charlotte NC, Charleston SC,
Sponsor: K36 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05651932

Phase 1, Recruiting

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

for
Advanced Solid Tumor, TNBC - Triple-Negative Breast Cancer,
Location: Atlanta GA, Ann Arbor MI, Coral Gables FL, Houston TX,
Sponsor: SillaJen, Inc.

Sex: All

Age: 18+

Code: NCT05768932

Phase 1, Recruiting

Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas

for
Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04883437

Phase 2, Recruiting

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

for
Advanced Solid Tumor, Non Small Cell Lung Cancer,
Location: Atlanta GA, Columbus OH, Fairfax VA, Washington D.C. DC,
Sponsor: Synthekine

Sex: All

Age: 18+

Code: NCT05098132

Phase 1, Phase 2, Recruiting

Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

for
Advanced Unresectable Solid Tumor, Metastatic Solid Tumor
Location: Atlanta GA, Birmingham AL, Columbus OH, Saint Louis MO,
Sponsor: TopAlliance Biosciences

Sex: All

Age: 18+

Code: NCT04137900

Phase 1, Recruiting

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Atlanta GA, Jacksonville FL, Durham NC, Columbus OH,
Sponsor: TORL Biotherapeutics, LLC

Sex: Female

Age: 18+

Code: NCT06690775

Phase 2, Recruiting

A Web-Based Dyadic Intervention for Colorectal Cancer

for
Colorectal Carcinoma
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT05663203

Recruiting

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

for
Glioblastoma, Recurrent Glioblastoma
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04590664

Phase 1, Phase 2, Recruiting

Trial of Trastuzumab Deruxtecan in Previously Treated HER2

for
Breast Cancer Metastatic
Location: Atlanta GA, Rochester NY, New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06750484

Phase 2, Recruiting

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer (NSCLC)
Location: Atlanta GA, Nashville TN, Chapel Hill NC, Tampa FL,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT07288177

Phase 2, Recruiting

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

for
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia,
Location: Atlanta GA, Durham NC, Columbus OH, St Louis MO,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 0+

Code: NCT04065399

Phase 1, Phase 2, Recruiting

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumor
Location: Atlanta GA, Nashville TN, Wilson NC, St Louis MO,
Sponsor: Pliant Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06270706

Phase 1, Recruiting